{"id":"https://openalex.org/W1963783567","doi":"https://doi.org/10.1016/j.taap.2007.03.031","title":"The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice","display_name":"The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice","publication_year":2007,"publication_date":"2007-04-21","ids":{"openalex":"https://openalex.org/W1963783567","doi":"https://doi.org/10.1016/j.taap.2007.03.031","mag":"1963783567","pmid":"https://pubmed.ncbi.nlm.nih.gov/17555784"},"language":"en","primary_location":{"id":"doi:10.1016/j.taap.2007.03.031","doi":"https://doi.org/10.1016/j.taap.2007.03.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.taap.2007.03.031","pdf_url":null,"source":{"id":"https://openalex.org/S42307217","display_name":"Toxicology and Applied Pharmacology","issn_l":"0041-008X","issn":["0041-008X","1096-0333"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology and Applied Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008576503","display_name":"Akihiko Hirose","orcid":"https://orcid.org/0000-0003-1703-4883","observed_orcids":["https://orcid.org/0000-0003-1703-4883"]},"institutions":[{"id":"https://openalex.org/I4210109111","display_name":"Amino Up (Japan)","ror":"https://ror.org/015999a88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210109111"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"A HIROSE","raw_affiliation_strings":["Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan","institution_ids":["https://openalex.org/I4210109111"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E SATO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109111","display_name":"Amino Up (Japan)","ror":"https://ror.org/015999a88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210109111"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"E SATO","raw_affiliation_strings":["Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan","institution_ids":["https://openalex.org/I4210109111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102937647","display_name":"Hideki Fujii","orcid":"https://orcid.org/0000-0003-1438-3690","observed_orcids":["https://orcid.org/0000-0003-1438-3690","https://orcid.org/0000-0001-7610-1068"]},"institutions":[{"id":"https://openalex.org/I4210109111","display_name":"Amino Up (Japan)","ror":"https://ror.org/015999a88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210109111"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"H FUJII","raw_affiliation_strings":["Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan","institution_ids":["https://openalex.org/I4210109111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109888588","display_name":"Biao Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109111","display_name":"Amino Up (Japan)","ror":"https://ror.org/015999a88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210109111"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"B SUN","raw_affiliation_strings":["Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan","institution_ids":["https://openalex.org/I4210109111"]}]},{"author_position":"middle","author":{"id":null,"display_name":"H NISHIOKA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109111","display_name":"Amino Up (Japan)","ror":"https://ror.org/015999a88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210109111"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"H NISHIOKA","raw_affiliation_strings":["Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amino Up Chemical Company, 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan","institution_ids":["https://openalex.org/I4210109111"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067970209","display_name":"Okezie I. Aruoma","orcid":"https://orcid.org/0000-0002-5119-4760","observed_orcids":["https://orcid.org/0000-0002-5119-4760"]},"institutions":[{"id":"https://openalex.org/I200437953","display_name":"Touro College","ror":"https://ror.org/05hwfvk38","country_code":"US","type":"education","lineage":["https://openalex.org/I200437953"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"O ARUOMA","raw_affiliation_strings":["Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, 230 West 125th Street, Harlem, New York, NY 10027, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, 230 West 125th Street, Harlem, New York, NY 10027, USA","institution_ids":["https://openalex.org/I200437953"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5067970209"],"corresponding_institution_ids":["https://openalex.org/I200437953","https://openalex.org/I4210109111"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":1.889,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.8399317,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"222","issue":"2","first_page":"152","last_page":"158"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11085","display_name":"Fungal Biology and Applications","score":0.01860000006854534,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/active-hexose-correlated-compound","display_name":"AHCC","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.890999972820282},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.7549999952316284},{"id":"https://openalex.org/keywords/hematopoietic-toxicity","display_name":"hematopoietic toxicity","score":0.7400000095367432},{"id":"https://openalex.org/keywords/anorexia","display_name":"anorexia","score":0.6880000233650208},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8560000061988831},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7490000128746033},{"id":"https://openalex.org/keywords/kidney-histopathology","display_name":"kidney histopathology","score":0.765999972820282},{"id":"https://openalex.org/keywords/blood-urea-nitrogen","display_name":"blood urea nitrogen","score":0.8289999961853027},{"id":"https://openalex.org/keywords/serum-creatinine","display_name":"serum creatinine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tumor-bearing-mice","display_name":"tumor-bearing mice","score":0.6959999799728394},{"id":"https://openalex.org/keywords/dietary-supplements","display_name":"dietary supplements","score":0.33000001311302185}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6616227626800537},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6512266397476196},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5963578224182129},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3453689515590668},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28740987181663513},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19755133986473083}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001806","descriptor_name":"Blood Urea Nitrogen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001855","descriptor_name":"Bone Marrow Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001855","descriptor_name":"Bone Marrow Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004435","descriptor_name":"Eating","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011134","descriptor_name":"Polysaccharides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011134","descriptor_name":"Polysaccharides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011134","descriptor_name":"Polysaccharides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019587","descriptor_name":"Dietary Supplements","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.taap.2007.03.031","doi":"https://doi.org/10.1016/j.taap.2007.03.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.taap.2007.03.031","pdf_url":null,"source":{"id":"https://openalex.org/S42307217","display_name":"Toxicology and Applied Pharmacology","issn_l":"0041-008X","issn":["0041-008X","1096-0333"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology and Applied Pharmacology","raw_type":"journal-article"},{"id":"pmid:17555784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17555784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology and applied pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1528896526","https://openalex.org/W1882728012","https://openalex.org/W1913200020","https://openalex.org/W1961111389","https://openalex.org/W1973369231","https://openalex.org/W1974004828","https://openalex.org/W1981803218","https://openalex.org/W1982759189","https://openalex.org/W1988894812","https://openalex.org/W1991724991","https://openalex.org/W1999030750","https://openalex.org/W2001066687","https://openalex.org/W2003572460","https://openalex.org/W2004122590","https://openalex.org/W2017292316","https://openalex.org/W2028062187","https://openalex.org/W2036604437","https://openalex.org/W2037951659","https://openalex.org/W2043039322","https://openalex.org/W2043497955","https://openalex.org/W2045714155","https://openalex.org/W2053540177","https://openalex.org/W2054510996","https://openalex.org/W2054626773","https://openalex.org/W2060123651","https://openalex.org/W2063060900","https://openalex.org/W2064240305","https://openalex.org/W2064696478","https://openalex.org/W2071568301","https://openalex.org/W2087856450","https://openalex.org/W2099252920","https://openalex.org/W2100714950","https://openalex.org/W2119766544","https://openalex.org/W2119983127","https://openalex.org/W2135198134","https://openalex.org/W2140680241","https://openalex.org/W2149866700","https://openalex.org/W2150605100","https://openalex.org/W2163581092","https://openalex.org/W2164277862","https://openalex.org/W2168631974","https://openalex.org/W2398356453","https://openalex.org/W2405040076"],"related_works":["https://openalex.org/W2064696478","https://openalex.org/W94681477","https://openalex.org/W4387653798","https://openalex.org/W2096110839","https://openalex.org/W3194384503","https://openalex.org/W4295897944","https://openalex.org/W1985021708","https://openalex.org/W3201593259","https://openalex.org/W4401186278","https://openalex.org/W4283721752"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}